Steven GurneyBSc, MIPLaw
Partner
Chartered (UK), European and Registered (AU, NZ) Patent Attorney
Offices:
Cambridge (UK)
Languages spoken:
English

Steven specialises in pharmaceutical patents with experience gained working both in-house and in private practice. He takes a collaborative approach, understanding his clients’ commercial drivers to deliver relevant, pragmatic and actionable advice. Steven advises multinationals, universities and start-ups in the fields of pharmaceuticals, chemistry and medical devices. His practice covers drafting, prosecution, portfolio management, freedom to operate (FTO), due diligence, advice, opposition and litigation.
Steven gained a BSc from Birmingham University in Chemistry and Biochemistry, joining Marks & Clerk in 2003 where he qualified as a UK and European patent attorney in 2006. Steven subsequently spent time working for a patent firm in Australia, obtaining a Masters in Intellectual Property and qualifying as an Australian and New Zealand patent attorney; and then in-house at the pharmaceutical company Mylan where he managed global launches from an IP perspective. Steven returned to Marks & Clerk in January 2017 and brings with him a wealth of in-house and private practice experience.
From 2019, Steven is a Guest Lecturer for the new MPhil in Therapeutic Sciences launched by the University of Cambridge and The Cambridge Academy of Therapeutic Sciences.
Steven is a 2021 Legal 500 key attorney and a 2016 Managing Intellectual Property Corporate IP Star.
Steven Gurney works in the following sectors
Biotechnology
Chemical
Pharmaceutical
.
Articles
Technical Notices for a "no-deal" Brexit
.
Articles
The European Commission’s “export manufacturing waiver” to SPCs
You may also be interested in...
.
Trade mark enforcement after Brexit
POSTED 16 December 2020